Abnormal Elevation of the Expression of Costimulatory Molecule CD226 in Graves' Disease: Two Cross-Sectional Studies
This study demonstrates for the first time the elevated expression of CD226 in CD4+ T cells and thyroid tissue of NOGD. The abnormal elevation of CD226 is correlated with clinical indicators. It suggests that the co-stimulatory molecule CD226 is involved in the pathogenesis of GD.
Authors
- Yuqing Wu (ORCID: https://orcid.org/0000-0002-5568-2390)
- Tiantian Cai (ORCID: https://orcid.org/0000-0001-9475-1654)
- Zhaowei Huang (ORCID: https://orcid.org/0000-0002-4086-0465)
- Yanfei Jiang (ORCID: https://orcid.org/0000-0002-2753-5254)
- Xinwei Zhang (ORCID: https://orcid.org/0009-0005-1479-6358)
- Jin‐an Zhang (ORCID: https://orcid.org/0000-0002-1700-4695)
- Xuerong Liu (ORCID: https://orcid.org/0000-0002-2897-7871)
- Rong-hua Song (ORCID: https://orcid.org/0000-0003-1466-5428)
Institutions
- Shanghai University of Traditional Chinese Medicine (CN)
- Yan'an University (CN)
- Shanghai University of Medicine and Health Sciences (CN)
Publication Details
- Journal
- Endocrine Metabolic & Immune Disorders - Drug Targets
- Published
- 2025-02-12
- DOI
- https://doi.org/10.2174/0118715303337480250107052116
- Primary Topic
- Cardiac Fibrosis and Remodeling
- Type
- article
- Field-Weighted Citation Impact
- 0.00